The FDA has accepted the New Drug Application for ET-600, an oral solution formulation of desmopressin, for the treatment of central diabetes insipidus.

Diabetes symptoms typically include increased thirst, urination, and hunger, among other things.

Several factors can contribute to hyperglycemia, including dietary choices and a sedentary lifestyle. Chronic high blood sugar is a symptom of diabetes.